These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 15708424)

  • 1. Sustained remission with lamotrigine augmentation or monotherapy in female resistant depressives with mixed cyclothymic-dysthymic temperament.
    Manning JS; Haykal RF; Connor PD; Cunningham PD; Jackson WC; Long S
    J Affect Disord; 2005 Feb; 84(2-3):259-66. PubMed ID: 15708424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclothymic temperament as a prospective predictor of bipolarity and suicidality in children and adolescents with major depressive disorder.
    Kochman FJ; Hantouche EG; Ferrari P; Lancrenon S; Bayart D; Akiskal HS
    J Affect Disord; 2005 Mar; 85(1-2):181-9. PubMed ID: 15780688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validating affective temperaments in their subaffective and socially positive attributes: psychometric, clinical and familial data from a French national study.
    Akiskal HS; Akiskal K; Allilaire JF; Azorin JM; Bourgeois ML; Sechter D; Fraud JP; Chatenêt-Duchêne L; Lancrenon S; Perugi G; Hantouche EG
    J Affect Disord; 2005 Mar; 85(1-2):29-36. PubMed ID: 15780673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclothymic temperament and major depressive disorder: a study on Italian patients.
    Maina G; Salvi V; Rosso G; Bogetto F
    J Affect Disord; 2010 Mar; 121(3):199-203. PubMed ID: 19556009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Affective temperaments in the bipolar and unipolar disorders: distinctive profiles and relationship with clinical features].
    Gassab L; Mechri A; Bacha M; Gaddour N; Gaha L
    Encephale; 2008 Oct; 34(5):477-82. PubMed ID: 19068336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociative experiences differentiate bipolar-II from unipolar depressed patients: the mediating role of cyclothymia and the Type A behaviour speed and impatience subscale.
    Oedegaard KJ; Neckelmann D; Benazzi F; Syrstad VE; Akiskal HS; Fasmer OB
    J Affect Disord; 2008 Jun; 108(3):207-16. PubMed ID: 18077000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bulimia nervosa in atypical depression: the mediating role of cyclothymic temperament.
    Perugi G; Toni C; Passino MC; Akiskal KK; Kaprinis S; Akiskal HS
    J Affect Disord; 2006 May; 92(1):91-7. PubMed ID: 16436300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamotrigine versus lithium augmentation of antidepressant therapy in treatment-resistant depression: efficacy and tolerability.
    Ivković M; Damjanović A; Jovanović A; Cvetić T; Jasović-Gasić M
    Psychiatr Danub; 2009 Jun; 21(2):187-93. PubMed ID: 19556947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
    Nierenberg AA; Ostacher MJ; Calabrese JR; Ketter TA; Marangell LB; Miklowitz DJ; Miyahara S; Bauer MS; Thase ME; Wisniewski SR; Sachs GS
    Am J Psychiatry; 2006 Feb; 163(2):210-6. PubMed ID: 16449473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperament in the clinical differentiation of depressed bipolar and unipolar major depressive patients.
    Mendlowicz MV; Akiskal HS; Kelsoe JR; Rapaport MH; Jean-Louis G; Gillin JC
    J Affect Disord; 2005 Feb; 84(2-3):219-23. PubMed ID: 15708419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine adjunctive treatment in resistant unipolar depression: an open, descriptive study.
    Gabriel A
    Depress Anxiety; 2006; 23(8):485-8. PubMed ID: 16845646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A downscaled practical measure of mood lability as a screening tool for bipolar II.
    Benazzi F; Akiskal HS
    J Affect Disord; 2005 Feb; 84(2-3):225-32. PubMed ID: 15708420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying hypomanic features in major depressive disorder using the hypomania checklist (HCL-32).
    Forty L; Smith D; Jones L; Jones I; Caesar S; Fraser C; Gordon-Smith K; Craddock N
    J Affect Disord; 2009 Apr; 114(1-3):68-73. PubMed ID: 18760487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium versus lamotrigine augmentation in treatment resistant unipolar depression: a randomized, open-label study.
    Schindler F; Anghelescu IG
    Int Clin Psychopharmacol; 2007 May; 22(3):179-82. PubMed ID: 17414745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypomanic, cyclothymic and hostile personality traits in bipolar spectrum illness: a family-based study.
    Savitz J; van der Merwe L; Ramesar R
    J Psychiatr Res; 2008 Sep; 42(11):920-9. PubMed ID: 18082182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between cyclothymic temperament and clinical predictors of bipolarity in recurrent depressive patients.
    Mechri A; Kerkeni N; Touati I; Bacha M; Gassab L
    J Affect Disord; 2011 Jul; 132(1-2):285-8. PubMed ID: 21377211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclothymic and hyperthymic temperaments may predict bipolarity in major depressive disorder: a supportive evidence for bipolar II1/2 and IV.
    Goto S; Terao T; Hoaki N; Wang Y
    J Affect Disord; 2011 Mar; 129(1-3):34-8. PubMed ID: 20699193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability and validity of TEMPS-A in a Japanese non-clinical population: application to unipolar and bipolar depressives.
    Matsumoto S; Akiyama T; Tsuda H; Miyake Y; Kawamura Y; Noda T; Akiskal KK; Akiskal HS
    J Affect Disord; 2005 Mar; 85(1-2):85-92. PubMed ID: 15780679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression.
    McElroy SL; Zarate CA; Cookson J; Suppes T; Huffman RF; Greene P; Ascher J
    J Clin Psychiatry; 2004 Feb; 65(2):204-10. PubMed ID: 15003074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.